Surfactant therapy using a bronchofiberscope in respiratory distress syndrome.

BACKGROUND: Avoiding endotracheal intubation and using nasal continuous positive airway pressure as the initial treatment is recommended in infants with respiratory distress syndrome (RDS), and modes of lesser invasive surfactant administration have recently been reported. We report a pilot study assessing the feasibility of surfactant therapy using a bronchofiberscope (STUB) in RDS. METHODS: Surfactant was administered to 31 preterm infants (gestational age range of 28 weeks 0 days to 36 weeks 6 days) diagnosed with RDS, through the working channel of the bronchofiberscope or endotracheal tubes. Patient characteristics, outcomes, adverse events, and comorbidities were assessed in the two groups. RESULTS: Twelve infants received STUB. Two of the 12 infants (17%) needed subsequent intubation and additional surfactant administration. Nineteen infants received surfactant through endotracheal tubes. Four of the 19 infants (21%) required additional surfactants. There was no significant difference in the number of infants that needed additional surfactant (p = 1.00). Gestational age, birthweight, length of hospitalization, adverse events, such as desaturations and bradycardias, and comorbidities were similar between the two groups. Days of invasive ventilation were significantly shorter in the STUB group (p = 0.0002). CONCLUSION: STUB was feasible in this small cohort and reduced the need for intubation to 17%, leading to fewer days of invasive ventilation, without increasing comorbidities and adverse events. To the best of our knowledge, this is the first study to administer surfactants using bronchofiberscopes.

Pharyngomalacia diagnosed by laryngo-tracheo-bronchoscopy in the neonatal intensive care unit.

BACKGROUND: Flexible fiber-optic laryngo-tracheo-bronchoscopy has become widely performed in infants and neonates since the introduction of thin flexible fiberscopes. Laryngomalacia is the most common airway disease in infants causing stridor. Pharyngomalacia, termed pharyngeal occlusion during inspiration, was the second most common airway disease found in our hospital in patients that underwent laryngo-tracheo-bronchoscopy, but the incidence, patient characteristics, and natural course have not been reported in large numbers in Japan. METHODS: A retrospective review was performed of medical records on patients admitted to our neonatal intensive care unit during the neonatal period diagnosed with pharyngomalacia between April 2009 and November 2018. Patient characteristics, concurrent airway diseases, comorbidities, and treatment were reviewed. RESULTS: Forty-eight patients were diagnosed with pharyngomalacia. The median gestational age was 37.1 weeks, and the median birthweight was 2,552 g. Patients were diagnosed at a median age of 29 days, and cure was achieved at a median age of 4 months. Twenty-eight patients had concurrent airway diseases, laryngomalacia being the most common. Continuous positive airway pressure or high flow nasal cannula was used in 34 patients. CONCLUSIONS: In patients with pharyngomalacia, half were born preterm, and more than half had concurrent airway diseases. The onset and diagnosis were made within the first month of life in more than half of the patients, and resolution was seen mostly within the first 6 months of life. Whenever a patient is suspected of having an airway disease, the pharyngeal space should be carefully observed to diagnose pharyngomalacia.

Videoendoscopic evaluation of swallowing using normal saline in NICU infants.

BACKGROUND: Videoendoscopic evaluation (VE) of swallowing involves inserting a small flexible endoscope transnasally to allow direct observation of pharyngeal and laryngeal structures and swallowing functions. In our neonatal intensive care unit (NICU) VE is performed in infants suspected of severe swallowing dysfunction, using normal saline (NS) with the aim of minimizing the detrimental effect of aspiration on respiration caused by VE. This retrospective study was conducted to evaluate the usefulness of VE using NS in NICU infants. METHODS: We enrolled 28 infants who demonstrated clinical signs of swallowing dysfunction or who were ready to start oral feeding. Swallowing evaluations were completed using flexible fiberoptic laryngobronchoscopy (FLB). While observing the pharyngeal and laryngeal cavity with FLB, NS was gradually increased by 1 mL and injected up to a maximum of 3 mL, and the swallowing reflex, tracheal aspiration, and pharyngeal residue were observed. RESULTS: Median gestational age was 37 weeks 6 days, median birthweight 2,539 g, and median age at first examination was 107.5 days. Abnormalities in VE were observed in 20 cases, most of which were upper airway lesions. Most of these upper airway abnormalities were pharyngeal lesions. In two pharyngeal lesion cases, swallowing function improved using positive airway pressure. CONCLUSIONS: Infants with pharyngeal lesions demonstrated abnormal VE findings. Furthermore, positive airway pressure improved swallowing in some cases, suggesting that narrowing of the pharyngeal cavity may affect swallowing function. In addition, results suggest that VE using NS is a safe and useful method for evaluating swallowing function and determining countermeasures in NICU infants.

Preoperative Treatment With Pazopanib in a Case of Chemotherapy-Resistant Infantile Fibrosarcoma.

Clinical and radiological diagnosis of infantile fibrosarcoma (IFS) is challenging because of its similarity to vascular origin tumors. Treatment involves complete resection. Although chemotherapy may allow more conservative resection, treatment guidelines are not strictly defined. One IFS patient with an unresectable tumor had disease progression during chemotherapy. A primary tumor sample showed high VEGFR-1/2/3 and PDGFR-α/ß expression. After pazopanib therapy, most tumor showed necrosis within 29 days and could be removed completely, with no relapse in 8 months post-resection. When IFS features hypervascularity, VEGFR and PDGFR expression may be high, thus allowing consideration of VEGFR inhibitors such as pazopanib.

Optical constants of silica glass from extreme ultraviolet to far infrared at near room temperature.

We thoroughly and critically review studies reporting the real (refractive index) and imaginary (absorption index) parts of the complex refractive index of silica glass over the spectral range from 30 nm to 1000 microm. The general features of the optical constants over the electromagnetic spectrum are relatively consistent throughout the literature. In particular, silica glass is effectively opaque for wavelengths shorter than 200 nm and larger than 3.5-4.0 microm. Strong absorption bands are observed (i) below 160 nm due to the interaction with electrons, absorption by impurities, and the presence of OH groups and point defects; (ii) at aproximately 2.73-2.85, 3.5, and 4.3 microm also caused by OH groups; and (iii) at aproximately 9-9.5, 12.5, and 21-23 microm due to Si-O-Si resonance modes of vibration. However, the actual values of the refractive and absorption indices can vary significantly due to the glass manufacturing process, crystallinity, wavelength, and temperature and to the presence of impurities, point defects, inclusions, and bubbles, as well as to the experimental uncertainties and approximations in the retrieval methods. Moreover, new formulas providing comprehensive approximations of the optical properties of silica glass are proposed between 7 and 50 microm. These formulas are consistent with experimental data and substantially extend the spectral range of 0.21-7 microm covered by existing formulas and can be used in various engineering applications.